EUVIMEDEUVIMED entdecken
Crossref

Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging

Patrick E Sewell

Aging · 13.02.2026 · 18 (1) · 1553-1563

DOI: 10.18632/aging.206440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, online erschienen am 13.11.2026. Verfasst von Patrick E Sewell. Beteiligte Einrichtung: Triple Helix Science, Santa Ana, CA 94025, USA. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial DNA mutations can contribute to respiratory dysfunction and aging phenotypes, but they have not been established as the universal initiating cause of human aging. This Perspective compares mitochondrial transplantation with a proposed gene therapy strategy without presuming therapeutic superiority. Transplantation supplies functional organelles and has encouraging evidence in selected models and small clinical studies of acute injury. Gene transfer could support sustained endogenous mitochondrial maintenance, although that advantage remains untested for systemic aging. Four candidate mechanisms are considered: TERT associated mitochondrial protection, TFEB mediated lysosomal quality control, POLG and TFAM dependent genome maintenance with selective respiratory subunit supplementation, and FGF21 mediated metabolic signaling. Their evidence ranges from cellular mechanisms and animal studies to clinical experience in distinct disease indications. Important limitations include tumor promotion, inappropriate autophagy or genome packaging, endocrine adverse effects, vector toxicity, and uncertain coordination of multiple transgenes. A staged comparison should measure tissue specific target engagement, pathogenic heteroplasmy, respiratory function, organ performance, and long-term safety. Neither approach has demonstrated systemic human age reversal. The proposed framework is a falsifiable research agenda, with potential complementarity between organelle replacement and endogenous maintenance.

Schlagwörter

Stichwörter der Autor:innen

aginggene therapymitochondrial DNAmitochondrial quality controlmitochondrial transplantation

Autor:innen und Institutionen

  • Triple Helix Science, Santa Ana, CA 94025, USA.

Zitieren

APA

Sewell, P. E. (2026). Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging. Aging, 18(1), 1553-1563. https://doi.org/10.18632/aging.206440

Vancouver

Sewell PE. Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging. Aging. 2026;18(1):1553-1563. doi:10.18632/aging.206440

BibTeX
@article{Sewell2026,
  author = {Sewell, Patrick E},
  title = {Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging},
  journal = {Aging},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {1553--1563},
  doi = {10.18632/aging.206440}
}
Kostenlos starten →